Thrombectomy for Distal Medium Vessel Occlusion: A Meta‐Analysis of Randomized Controlled Trials
Journal of the American Heart Association · 21.10.2025 · 14 (20)
DOI: 10.1161/jaha.125.042299 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of the American Heart Association, erschienen am 21.10.2025. Verfasst von Hong-Jie Jhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Institute Changhua Christian Hospital Changhua Taiwan. Hauptthemen laut MEDLINE: Thrombectomy, Ischemic Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Approximately 25% to 40% of all acute ischemic strokes result from distal medium vessel occlusions. However, the effectiveness and safety of thrombectomy for distal medium vessel occlusions remain uncertain.
Methods
A systematic search of PubMed, Cochrane, and Embase was conducted for randomized controlled trials published until February 2025. The primary outcomes were functional outcomes at 90 days (excellent, good, and favorable). The secondary outcomes included symptomatic intracranial hemorrhage (ICH), any ICH, and mortality at 90 days.
Results
Three studies involving 1246 patients with stroke with distal medium vessel occlusion were included (614 patients receiving thrombectomy; others with medical management). At 3 months, the odds ratio for an excellent functional outcome was 0.92 (95%, 0.72–1.17), for a good functional outcome was 0.87 (95% CI, 0.70–1.09), and for a favorable functional outcome was 0.84 (95% CI, 0.64–1.10), indicating no significant difference between the 2 groups. However, thrombectomy was associated with a higher risk of hemorrhage, with an odds ratio of 2.18 (95% CI, 1.24–3.83) for symptomatic ICH and 1.96 (95% CI, 1.54–2.50) for any ICH. Mortality at 3 months was similar between the groups, with an odds ratio of 1.20 (95% CI, 0.85–1.70).
Conclusions
Thrombectomy did not significantly improve functional outcomes or reduce mortality but increased symptomatic ICH and any ICH. Further recent randomized controlled trials are needed to define subgroups that may benefit. Registration PROSPERO CRD420251073344.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neurological Institute Changhua Christian Hospital Changhua Taiwan.
- Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital National Defense Medical University Taipei Taiwan.
- Department of Neurology Chang Bing Show Chwan Memorial Hospital Changhua Taiwan.
ORCID-Profile: Hong-Jie Jhou, Wei-Sheng Wang, Cho-Hao Lee, Li-Yu Yang, Po-Huang Chen
Zitieren
APA
Jhou, H. J., Wang, W. S., Lee, C. H., Yang, L. Y., & Chen, P. H. (2025). Thrombectomy for Distal Medium Vessel Occlusion: A Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 14(20). https://doi.org/10.1161/jaha.125.042299
Vancouver
Jhou HJ, Wang WS, Lee CH, Yang LY, Chen PH. Thrombectomy for Distal Medium Vessel Occlusion: A Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2025;14(20). doi:10.1161/jaha.125.042299
BibTeX
@article{Jhou2025,
author = {Jhou, Hong-Jie and Wang, Wei-Sheng and Lee, Cho-Hao and Yang, Li-Yu and Chen, Po-Huang},
title = {Thrombectomy for Distal Medium Vessel Occlusion: A Meta‐Analysis of Randomized Controlled Trials},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {20},
doi = {10.1161/jaha.125.042299}
}
EUVIMED